Oxana
Oxana Beskrovnaya, Southborough, MA US
Patent application number | Description | Published |
---|---|---|
20110046164 | Purine Derivatives for Treatment of Cystic Diseases - Provided herein are methods of treatment of a cystic disease by administering a compound of Formula I. In certain embodiments, the compound for use in the methods provided herein is roscovitine or an analog thereof. | 02-24-2011 |
20140249165 | PURINE DERIVATIVES FOR TREATMENT OF CYSTIC DISEASES - Provided herein are methods of treatment of a cystic disease by administering a compound of Formula I. In certain embodiments, the compound for use in the methods provided herein is roscovitine or an analog thereof. | 09-04-2014 |
Oxana Ciobanu, Eppelheim DE
Patent application number | Description | Published |
---|---|---|
20100172825 | Molecular Hydrogen Stores and Hydrogen Transfer Reagents for Hydrogenation Reactions - The present invention relates to a process for reversible hydrogen storage, to a material for reversible hydrogen storage and to the use of the material for reversible hydrogen storage. | 07-08-2010 |
Oxana Guerassimenko, Milly-La-Foret FR
Patent application number | Description | Published |
---|---|---|
20100310641 | THERAPEUTIC APPROACHES FOR TREATING CMT AND RELATED DISORDERS - The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders. More particularly, the invention relates to combined therapies for treating said disease by affecting PMP22 expression in a subject. | 12-09-2010 |
20110269764 | THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION - The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that modulate synapse function for treating said disease. | 11-03-2011 |
20120040940 | COMBINATION OF PILOCARPIN AND METHIMAZOL FOR TREATING CHARCOT-MARIETOOTH DISEASE AND RELATED DISORDERS - The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related peripheral neuropathies. More particularly, the invention relates to combined therapies for treating said disease by affecting simultaneously muscarinic receptor signaling and thyroid hormone pathway in a subject. | 02-16-2012 |
20120058992 | THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF ANGIOGENESIS - The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that modulate angiogenesis for treating said disease. | 03-08-2012 |
20120071483 | THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF CELL STRESS RESPONSE - The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that modulate cell stress response for treating said disease. | 03-22-2012 |
20120283114 | NEW DIAGNOSTIC TOOLS FOR ALZHEIMER DISEASE - The present invention relates to development, validation and application of new sets of biomarkers for diagnosis of Alzheimer's disease (AD) and related disorders including early diagnosis of MCI and early prodrome of AD, identification of disease sub types, prediction of their response to disease management procedures, drugs and their combinations and for monitoring response for these treatment, including validation of biomarkers for clinical trials. | 11-08-2012 |
20130217036 | NEW DIAGNOSTIC TOOLS FOR CHARCOT-MARIE-TOOTH DISEASE - The present invention relates in particular to methods of detecting predisposition to or diagnosis and/or prognosis of Charcot-Marie-Tooth (CMT) and related disorders. More specifically, the invention relates to development, validation and application of new biomarkers, which can be used for detecting the presence or risk of CMT disease and related disorders. In particular, the present invention relates to metabolite, lipid, carbohydrate and proteinaceous biomarkers that can be measured in biological body fluids and easily available extracts of biopsies, which can be used to aid in the detection, prediction of drug treatment and follow up of this treatment of neurodegenerative disorders, including CMT disease. The present invention also relates to methods for identification of CMT disease subtypes, assessing the responsiveness to the treatments and the efficacy of treatments in subjects having CMT or a related disorder. | 08-22-2013 |
20140235599 | COMBINATION OF PILOCARPIN AND METHIMAZOL FOR TREATING CHARCOT-MARIETOOTH DISEASE AND RELATED DISORDERS - The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related peripheral neuropathies. More particularly, the invention relates to combined therapies for treating said disease by affecting simultaneously muscarinic receptor signalling and thyroid hormone pathway in a subject. | 08-21-2014 |
Oxana Ibraghimov-Beskrovnaya, Southborough, MA US
Patent application number | Description | Published |
---|---|---|
20110166134 | Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease - A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject comprises administering to the subject an effective amount of a glucosylceramide synthase inhibitor. | 07-07-2011 |
20130225573 | GLUCOSYLCERAMIDE SYNTHASE INHIBITION FOR THE TREATMENT OF COLLAPSING GLOMERULOPATHY AND OTHER GLOMERULAR DISEASE - A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject comprises administering to the subject an effective amount of a glucosylceramide synthase inhibitor. | 08-29-2013 |
20140336174 | Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease - A method of treating a glomerular disease selected from the group consisting of mesangial proliferative glomerulonephritis, collapsing glomerulopathy, proliferative lupus nephritis, crescentic glomerulonephritis and membranous nephropathy in a subject comprises administering to the subject an effective amount of a glucosylceramide synthase inhibitor. | 11-13-2014 |
Oxana Ibraghinov-Beskrovnaya, Southborough, MA US
Patent application number | Description | Published |
---|---|---|
20100298317 | METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES WITH CERAMIDE DERIVATIVES - A method of treating polycystic kidney disease in a subject comprises administering to the subject an effective amount of a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. | 11-25-2010 |
Oxana Savvatyeyev, Holon IL
Patent application number | Description | Published |
---|---|---|
20130257575 | COIL HAVING LOW EFFECTIVE CAPACITANCE AND MAGNETIC DEVICES INCLUDING SAME - A coil of a magnetic device comprising a conductor having its plurality of turns arranged in a plurality of conductive layers, wherein at least two non-innermost and electrically consecutive turns of the conductor are arranged in different conductive layers, and a magnetic device including same. | 10-03-2013 |
20130299131 | ADJUSTABLE HEAT DISSIPATION ASSEMBLY FOR MAGNETIC DEVICES - According to embodiments of the present invention, there is provided an adjustable heat dissipation assembly and a method for manufacturing and assembling same. The heat dissipation assembly may include: a heat dissipation frame including a base with at least two side walls, the base and the side walls define an internal space suitable for accommodating a device that requires cooling; and an adjustable plate, configured to be placed over the device in between the side walls, and secured to the side walls, the distance of the adjustable plate from the base of the heat dissipation frame when it is not secured to the side walls being adjustable. | 11-14-2013 |